Abstr#1802 - nice study from @CleClinicMD confirming low clinical value of annual quantiferon screening for LTBI in the absence of new or ongoing risk factor #ACR2019 @RheumNow @ElaineHusniMD #cleclinicrheum

Abstr#1806: Another centre’s experience with IA-irAEs from ICIs #ACR19 @RheumNow https://t.co/OFZaYqMSFR

Don’t forget to check immunoglobulins prior to starting Rituximab! Thanks for sharing our results! @hausmannMD #ACR19 @RheumNow https://t.co/PNGe72waez

• Jonathan Hausmann MD on Twitter: "After rituximab use, patients with ANCA-…

Beware hydralazine! Associated vasculitis with high frequency of CKD and poor outcomes. 100%renal involvement and ANCA positivity! Abstr#1667 @SajaAlmaaitah @kinanah9 @CleClinicMD #cleclinicrheum #ACR19 @RheumNow https://t.co/qJM49xN6Rx

Abstr#824 VERVE results - safety of live heroes zoster vaccine in pts on TNFi- no cases of vaccine-related varicella @LCalabreseDO @BetsyKirch @RheumNow #ACR19 #cleclinicrheum https://t.co/zPDvQujgzP

Excellent irAE summary by Ryan Sullivan -judicious use of steroids, High doses when needed, low dose when possible. Pre-existing AID not a contradiction to checkpoint inhibitor Tx! @RheumNow @LCalabreseDO @cappelliMD @lexmeara #ACR19 #cleclinicrheum https://t.co/TOTXQzxXhp

Do you co-manage your PsO/PsA patients with dermatology? #ACR19 @RheumNow

So glad that our clinical study from @RBNHSFT looking at the outcome measures in Axial Spondyloarthritis eg. BASDAI, ASDAS, CRP, BASFI and the impact on response to treatment was delivered today as an oral presentation with good feedback at #ACR19 #axialspondyloarthritis

Continued Ixekizumab was superior to PBO in maintaining MDA in biologic-naïve PsA pts who achieved sustained MDA on initial IXE treatment. A vast majority of pts who lost MDA after IXE withdrawal regained MDA with IXE re-treatment presented by @DrLauraCoates #ACR19 @RheumNow

Relapsing Polychondritis: a 4th more worrying phenotype #ACR19 @rheumnow 4M086 https://t.co/4EAgBb07cV

Relapsing Polychondritis: 3 more common clinical phenotypes #ACR19 @rheumnow 4M086 https://t.co/aqNQMYCao2

Relapsing Polychondritis: speaker’s recommendations #ACR19 @rheumnow 4M086 https://t.co/G2TIOfTGiW